Clinical Trials on Epilepsies, Partial

Total 4934 results

UCB Pharma

Completed

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure (SELF)

Partial Epilepsies

France
UCB Pharma

Completed

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies

United States, Poland, United Kingdom, Switzerland, Hungary, Germany, Sweden, Lithuania
UCB BIOSCIENCES, Inc.

Completed

Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
Institut National de la Santé Et de la Recherche...

Unknown

Structural and Functional Connectivity in Partial Epilepsies Studied With MRI and MEG

Epilepsies

France
UCB BIOSCIENCES, Inc.

Completed

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Partial Epilepsies

United States
UCB Pharma

Completed

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Partial Epilepsies

United States, Austria, Bulgaria, Czechia, Denmark, Finland, France, Greece, Italy, Mexico, Romania, Russian Federation, Spain, Switzerland, Turkey
UCB BIOSCIENCES, Inc.

Completed

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Partial Epilepsies | Partial Onset Seizures

United States
Vertex Pharmaceuticals Incorporated

Terminated

A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy

Epilepsy

United States, Germany
Bial - Portela C S.A.

Completed

Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive

Partial Epilepsy

Portugal
GlaxoSmithKline

Completed

Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

Epilepsy
GlaxoSmithKline

Completed

An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

Epilepsy, Partial
Biocodex

Recruiting

Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies

Pharmacoresistant Focal Epilepsies

France
Rennes University Hospital

Completed

Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy (BRAINSTIM)

Epilepsy

France
GlaxoSmithKline

Withdrawn

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

Epilepsy, Partial

Japan
Supernus Pharmaceuticals, Inc.

Completed

Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy

Partial Epilepsy

United States, Poland, Bulgaria, Romania, Canada, Russian Federation, Mexico, Croatia
Central Hospital, Nancy, France
Institut National de la Santé Et de la Recherche Médicale, France; CHU de Reims and other collaborators

Completed

Localizing the Epileptogenic Zone With High Resolution Electroencephalography (EEG-HR)

Partial Epilepsy

France
Eisai Inc.

Completed

A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy

Epilepsy

Australia, France, Poland, Germany, Spain, India, Serbia, Greece, Korea, Republic of, Russian Federation, Taiwan, Hungary, Italy, Sweden, Denmark, Slovakia, United Kingdom, South Africa
Mayo Clinic

Completed

Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy

Epilepsy

United States
Cyberonics, Inc.

Terminated

Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients

Epilepsy | Partial Epilepsy

Canada, Spain, Belgium, France, Germany, Italy, Netherlands, Norway, Sweden, United Kingdom
Vertex Pharmaceuticals Incorporated

Completed

Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy

Partial Epilepsy

United States
University of Minnesota

Completed

Neural Correlates of Cognition and Mood

Epilepsy, Complex Partial

United States
Supernus Pharmaceuticals, Inc.
Melbourne Health

Completed

Bioavailability, Safety, and Tolerability of BIS-001 ER

Epilepsy, Complex Partial

Australia
University Hospital, Toulouse

Recruiting

Intracerebral Electrical Stimulation and the Optimisation of Presurgical Planning in Drug-refractory Partial Epilepsy (StiMiC)

Epilepsy

France
UCB Pharma

Completed

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

Epilepsy, Partial
University Hospital, Toulouse
CerCo, CNRS Cerco UMR5549 CHU Purpan Toulouse France; DIXI Medical, Besançon...

Completed

Recording "Fast Ripples" Using Microelectrodes During Stereo-encephalography in Patients With Drug-resistant Partial Epilepsy (Epi-FaR)

Epilepsy

France
Eisai Korea Inc.

Completed

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

Epilepsy

Korea, Republic of
Korea UCB Co., Ltd.

Completed

Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (OPTIMAL)

Epilepsy

Korea, Republic of
Bial - Portela C S.A.

Completed

Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine

Partial Epilepsy

Belgium
UCB Pharma

Completed

Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.

Epilepsy, Partial
UCB Pharma

Completed

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

Epilepsy
UCB Pharma

Completed

Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy, Partial
Hospices Civils de Lyon

Unknown

Multimodal Imaging in Pre-surgical Evaluation of Epilepsy (EPIMAGE)

Partial Epilepsy

France
Desitin Arzneimittel GmbH
FGK Clinical Research GmbH

Terminated

EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy

Partial Epilepsy

Germany
Pfizer

Completed

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Epilepsy, Partial

United States, Germany
University Hospital, Grenoble

Completed

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy (FRANCE)

Surgery | Partial Epilepsy

France
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain (EPITRACT)

Drug Resistant Epilepsy | Pediatrics | Epilepsies, Focal

France
Emory University
Patient-Centered Outcomes Research Institute

Terminated

Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) (COPE)

Epilepsy, Partial | Epilepsy, Localization Related

United States
The Hospital for Sick Children

Completed

Improving Lesion Detection in Children With Magnetic Resonance Imaging (MRI)-Negative Partial Epilepsy Using Diffusion Tensor Imaging

Partial Epilepsy | Localization-related Epilepsy

Canada
Atlantic University
A.T. Still University of Health Sciences

Completed

Thermographic Examination of Skin Temperatures in Individuals With Focal Onset Epilepsy

Partial Epilepsy | Focal Onset Epilepsy

United States
SK Life Science, Inc.

Approved for marketing

Cenobamate Expanded Access Program (EAP)

Partial Epilepsy
UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Epilepsy, Partial

Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Thailand
Bial - Portela C S.A.

Completed

Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy

Partial Epilepsy

Portugal
GlaxoSmithKline

Completed

Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304

Epilepsy, Partial
Bial - Portela C S.A.
Sunovion

Completed

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Partial Epilepsy

United States, Argentina, Germany, France, Belgium, Canada, Italy, Poland, Greece, Brazil, Cyprus
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Refractory Partial Epilepsy

Portugal
Northeast Regional Epilepsy Group
Pfizer

Terminated

Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin

Epilepsy, Complex Partial

United States
GlaxoSmithKline

Completed

Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

Epilepsy, Partial

United States, Korea, Republic of, Ukraine, Chile, Costa Rica, Russian Federation, Puerto Rico, Argentina
The Cleveland Clinic
UCB Pharma

Completed

Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy

Partial Epilepsy

United States
UCB Pharma

Completed

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Epilepsy, Partial
UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Epilepsy, Partial

3

Subscribe